tgf-β codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation

Authors

ali rashidi–nezhad department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran,

cyrus azimi department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran,

kamran alimoghaddam hematology–oncology and bmt research center, shariati hospital, tehran university of medical science

ardeshir ghavamzadeh hematology–oncology and bmt research center, shariati hospital, tehran university of medical science

abstract

some of the genotypes of cytokines are associated with acute graft versus host disease after bone marrow transplantation. the purpose of the present investigation was to find out the possible association between transforming growth factor beta-1 (tgf-β1) codon 25 polymorphism (rs:1800471) and acute graft versus host disease (agvhd) after bone marrow transplantation from the sibling with the similar hla among the iranian population. in this retrospective case-control investigation, 172 subjects including 86 iranian patients and their siblings with the similar hla as donor/recipient pairs were recruited. all of the patients were diagnosed with one group of blood disorder consisting of acute myeloid leukemia (aml)=40, acute lymphoblastic leukemia (all)=25 and chronic myeloid leukemia (cml)=21. pcr-ssp method was carried out to ascertain tgf- β1 codon 25 g/c polymorphism genotypes. the frequency of tgf- β1 codon 25 gg, gc and cc genotypes among all cases were 77.3%, 21.5% and 1.2%, respectively. recipients with the gg genotype developed severe agvhd significantly more than those with cc or gc genotypes (odds ratio =12.133, p=0.015). genetic background of tgf-β1 may be involved in agvhd development and/or severity in the patients who received bone marrow transplantation (bmt) from their siblings with the similar hla among the iranian population.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Relationship between Molecular Chimerism and Graft Versus Host Disease after Allogenic Hematopoietic Stem Cell Transplantation

Background: Bone marrow transplantation (BMT) is considered as a curative therapy for a broad range of diseases. However, complications such as relapse and graft versus host disease (GVHD) may be observed following BMT. Chimerism analysis serves as a reliable indicator of transplant outcome. Complete chimerism refers to the complete replacement of hematopoietic system by donor cells, while mixe...

full text

Assessment of Cyclosporine Serum Concentrations on the Incidence of Acute Graft versus Host Disease Post Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option for hematological disorders. Cyclosporine (CsA) is one of the major immunosuppressive agents for the prophylaxis against graft versus host disease (GvHD). In this retrospective study, we evaluated the effects of CsA serum levels on the incidence of acute GvHD and transplant outcomes. 103 adult patients rece...

full text

Assessment of Cyclosporine Serum Concentrations on the Incidence of Acute Graft versus Host Disease Post Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option for hematological disorders. Cyclosporine (CsA) is one of the major immunosuppressive agents for the prophylaxis against graft versus host disease (GvHD). In this retrospective study, we evaluated the effects of CsA serum levels on the incidence of acute GvHD and transplant outcomes. 103 adult patients rece...

full text

Evaluation of Serum Interleukin-21 and HLA-C1 Polymorphism in Pediatrician Hematopoietic Stem Cell Transplantation for Early Diagnosis of Acute Graft-Versus-Host Disease

Background: Allogenic hematopoietic stem cell transplantation (HSCT) is a strategy used for treatment of different malignant diseases. However, success of allo-HSCT can be hampered by graft-versus-host-disease (GVHD). Natural killer (NK) cells may play an important role in activating antigen presenting cells and subsequent activation of T cells. The main purpose of this study was the evaluation...

full text

Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation.

CONTEXT AND OBJECTIVE Graft-versus-host disease (GVHD) is one of the complications following allogenic stem cell transplantation. This study investigated an association between human leukocyte antigen (HLA) and the occurrence of acute and chronic GVHD in patients who had received stem cell transplantations from HLA-identical siblings. DESIGN AND SETTING Retrospective study at Hematology and H...

full text

Haploidentical hematopoietic stem cell transplantation for graft-versus-host disease after liver transplantation.

3. Kothari H, Rao LV, Pendurthi U. Cys186-Cys209 disulfide–mutated tissue factor does not equal cryptic tissue factor: no impairment in decryption of disulfide mutated tissue factor. Blood. 2010;116(3):502-503. 4. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood. 2007;110(12):3900-3908. 5. Chen VM, Ahamed J, Versteeg H...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of allergy, asthma and immunology

جلد ۹، شماره ۱، صفحات ۱-۶

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023